Genmab A/S (GMAB)
30.06
-0.54
(-1.76%)
USD |
NASDAQ |
Feb 11, 16:00
30.06
0.00 (0.00%)
After-Hours: 20:00
Genmab Total Liabilities (Quarterly) : 1.270B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AbbVie, Inc. | -- |
| Krystal Biotech, Inc. | 102.22M |
| Novo Nordisk A/S | 54.85B |
| Ascendis Pharma A/S | 1.561B |
| Zealand Pharma A/S | 257.31M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.021B |
| Shareholders Equity (Quarterly) | 5.751B |
| Debt to Equity Ratio | 0.0247 |
| Current Ratio | 6.034 |
| Net Debt Paydown Yield | 0.00% |